DYNAMIS PHARMACEUTICALS

dynamis-pharmaceuticals-logo

Dynamis Pharmaceuticals, Inc. is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases. Its proprietary drug candidates inhibit a novel enzymatic pathway that causes the formation of a highly reactive sugar, 3-deoxyglucosone, that stimulates the production of Advanced Glycation End Products (AGEs), oxidative stress and a cascade of inflammatory cytokines.

#Financial #Website #More

DYNAMIS PHARMACEUTICALS

Industry:
Biotechnology

Founded:
1997-01-01

Address:
Jenkintown, Pennsylvania, United States

Country:
United States

Website Url:
http://www.dynamis-therapeutics.com

Total Employee:
51+

Status:
Active

Contact:
(215)376-5290

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Apache Microsoft Exchange Online Microsoft Azure DNS Network Solutions DNS Symantec Secure Site Citrix NetScaler Confluence Networks


Investors List

bioadvance_image

BioAdvance

BioAdvance investment in Seed Round - Dynamis Pharmaceuticals

Official Site Inspections

http://www.dynamis-therapeutics.com

Unable to get host informations!!!

Loading ...

More informations about "Dynamis Pharmaceuticals"

DYNAMIS THERAPEUTICS, INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for DYNAMIS THERAPEUTICS, INC. of Jenkintown, PA. Get the latest business insights from Dun & …See details»

Dynamis Therapeutics Inc - Company Profile and News

Company profile page for Dynamis Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»

Dynamis Therapeutics - Company Profile - Tracxn

Dynamis Therapeutics ranks 124th among 217 active competitors. 81 of its competitors are funded while 43 have exited. Overall, Dynamis Therapeutics and its competitors have raised …See details»

Dynamis Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Explore Dynamis Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 2 literature.See details»

DYNAMIS THERAPEUTICS, INC. :: Pennsylvania (US)

Jul 20, 2006 Free and open company data on Pennsylvania (US) company DYNAMIS THERAPEUTICS, INC. (company number 2756735), 261 Old York Road Suite 427, …See details»

DYNAMIS THERAPEUTICS, INC. - VentureRadar

Similar Companies: NEURONEXUS TECHNOLOGIES USA n/a NeuroNexus Inc. is a high-growth commercial life science company that specializes in neurotechnology, neuroscience, and …See details»

Dynamis Therapeutics, Inc.: Contact Details and Business Profile

Dynamis Therapeutics, Inc. is a Biotechnology, Pharmaceuticals, and Science and Engineering company_reader located in Jenkintown, Pennsylvania with $8.8 million in revenue and 0 …See details»

Dynamis Therapeutics, Inc.:Company Profile & Technical Research ...

Dynamis Therapeutics, Inc. is headquartered in United States Pennsylvania. Dynamis Therapeutics, Inc. was founded in 1997. Dynamis Therapeutics, Inc. has a total of 52 patents . …See details»

Dynamis Therapeutics, Inc. | Life Sciences PA - Default Site

Dynamis Therapeutics is focused on the discovery and development of therapeutic pharmaceuticals to treat and prevent diabetic complications resulting from glucose induced …See details»

Dynamis Therapeutics, Inc. - Company Information, Competitors, …

Find useful insights on Dynamis Therapeutics, Inc.'s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Dynamis …See details»

Dynamis Therapeutics, Inc - LinkedIn

Dynamis Therapeutics, Inc | 28 followers on LinkedIn. ... Ben Franklin Technology Partners Venture Capital and Private Equity PrincipalsSee details»

DYNAMIS THERAPEUTICS, INC. - VentureRadar

DYNAMIS THERAPEUTICS, INC. VentureRadar profile. Find out more about DYNAMIS THERAPEUTICS, INC. including the VentureRadar Innovation and Growth scores, Similar …See details»

Dynamis Therapeutics Inc. :: In Vivo

Dec 1, 1997 This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183See details»

Dynamis Therapeutics founders & board of directors - Tracxn

Oct 22, 2024 Annette Tobia, Founder, President & CEO at Dynamis TherapeuticsFounder, President & CEO; at Dynamis TherapeuticsContact information: 1 email; View all details about …See details»

Dynamis Pharmaceuticals - Crunchbase Company Profile & Funding

Dynamis Pharmaceuticals, Inc. is a biopharma company that is developing proprietary small molecule drugs to treat chronic inflammatory diseases. Its proprietary drug candidates inhibit a …See details»

Dynamis Therapeutics - Raised $1.5M Funding from 1 investor

Oct 22, 2024 Dynamis Therapeutics has raised a total funding of $1.5M over 4 rounds from 1 investor. Investor includes Ben Franklin Technology Partners. Their latest funding round was …See details»

DYNAMIS THERAPEUTICS, INC. | SBIR.gov

DESCRIPTION (provided by applicant): The glucose metabolite 3-deoxyglucosone (3DG) is a highly reactive, dicarbonyl, proinflammatory molecule that induces oxidative stress and is a …See details»

DYNAMIS THERAPEUTICS INC innovation strategy - GoodIP

DYNAMIS THERAPEUTICS INC has a total of 52 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2002. It filed its patents most often in United …See details»

Dynamis Therapeutics Discovers RAGE Inhibitor Potential to …

Mar 19, 2008 A team of Dynamis Therapeutics' scientists significantly decreased kidney and retina RAGE in aged rats that were orally dosed with Dynamis Therapeutics' RAGE inhibitor …See details»

Synamics Therapeutics | AI drug discovery

Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and …See details»

linkstock.net © 2022. All rights reserved